Related Experiment Videos
Current perspectives on vitamin E in infant nutrition
Insights
Infants need vitamin E (tocopherol) after birth to prevent deficiency diseases like anemia. The benefits and risks of high-dose vitamin E for premature infants are still unclear.
Area of Science:
- Neonatal nutrition
- Pediatric pharmacology
- Biochemistry
Background:
- Human infants are born with limited vitamin E (tocopherol) reserves.
- Vitamin E deficiency in infants can lead to hemolytic anemia and spinocerebellar degeneration.
- The prophylactic use of pharmacologic vitamin E doses against oxygen-related diseases in neonates is not well-established.
Purpose of the Study:
- To evaluate the unclear benefits of pharmacologic vitamin E doses for preventing oxygen toxicity-related diseases in infants.
- To assess the potential risks and toxicity associated with high-dose vitamin E administration in neonates.
- To investigate the limited pharmacokinetic data of tocopherols, especially esterified forms, in infants.
Main Methods:
- Review of existing literature on vitamin E in infant nutrition and supplementation.
- Analysis of data regarding the efficacy and safety of vitamin E in preventing bronchopulmonary dysplasia, retinopathy of prematurity, and intraventricular hemorrhage.
- Examination of available pharmacokinetic and toxicity data for parenteral vitamin E in neonates.
Main Results:
- The benefits of pharmacologic vitamin E for preventing oxygen toxicity-related conditions in infants remain uncertain.
- Potential serious toxicities must be weighed against any proposed benefits.
- There is a lack of comprehensive data on tocopherol pharmacokinetics and parenteral toxicity in infants.
Conclusions:
- The clinical utility of high-dose vitamin E supplementation in neonates requires further investigation.
- Balancing potential benefits against toxicity risks is crucial when considering vitamin E therapy.
- More research is needed on vitamin E pharmacokinetics and safety in the neonatal population.
Abstract:
The human infant is born with low body stores of vitamin E. Thus, the infant requires an adequate intake of vitamin E soon after birth. If adequate sources of tocopherol are not provided, a clearly defined deficiency state characterized by hemolytic anemia and, after a period of years, spinocerebellar degeneration results. However, the benefit of pharmacologic doses of vitamin E given as prophylaxis against diseases believed to be related to oxygen toxicity (bronchopulmonary dysplasia, retinopathy of prematurity, and periventricular-intraventricular hemorrhage) is not clear. Possible benefits must be balanced against the potential for serious toxicity. Few data are available on the pharmacokinetics of tocopherols in infants, particularly with respect to esterified forms of tocopherol, and little is known about the toxicity associated with parenteral administration of the vitamin.